Editorial: Shrinking the myocardial infarct.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001243:Assisted Circulation; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D008729:Methoxamine / Q000494:pharmacology / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D010101:Oxygen Consumption / Q000187:drug effects; D010313:Partial Pressure; D011379:Prognosis; D012770:Shock, Cardiogenic / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D008729:Methoxamine